Conditions: Insomnia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 411
Healthy volunteers: yes

Brief summary:
The purpose of this study is to determine the safety and efficacy of VEC-162 compared to placebo to improve sleep parameters in a model of insomnia.

Detailed description:

Arms:
arm 1: Take orally 30 minutes prior to bedtime. arm 2: 20 mg taken orally 30 minutes prior to bedtime. arm 3: 50 mg taken orally 30 minutes prior to bedtime. arm 4: 100 mg taken orally 30 minutes prior to bedtime.

Interventions: intervention 1: 20 mg VEC-162 intervention 2: 50 mg VEC-162 intervention 3: 100 mg VEC-162 intervention 4: Placebo
Intervention descriptions: intervention 1: 20 mg VEC-162 intervention 2: 50 mg VEC-162 intervention 3: 100 mg VEC-162 intervention 4: Placebo

Protocol document: